AReNA Panel: Beyond the success of pandemic vaccines
AReNa Quebec will be hosting the following panel on April 30th:
Beyond the success of pandemic vaccines: what are the challenges and opportunities in the development and biomanufacturing of RNA therapies?
Synopsis:
This panel will provide a unique opportunity to build on the successes of mRNA during the pandemic and discuss the future evolution of RNA therapies as a whole. The panelists will highlight the challenges and opportunities, including potential collaborations between stakeholders in Quebec, Canada, and internationally. They will shed light on key issues and recent advances, contributing to a strategic reflection on the future of these therapeutic innovations. Will we be able to leverage these insights?
Objectives:
Building on the achievements of vaccines and exploring the challenges and opportunities related to the development and production of RNA therapies.
Showcasing Quebec’s RNA sector and its international positioning.
Panelists:
Eileen Raymond (Director of Life Sciences Special Initiatives at the National Research Council of Canada) – Panel Moderator
Germain Morin (Former VP Global Supply Chain at Pfizer – Developed and managed the global supply chain for the Pfizer COVID vaccine)
James Mansi (Vice President Medical Affairs, Moderna)
Kanta Subbarao (Professor, Laval University – Virologist and pediatric infectious disease specialist, former Director of the WHO Collaborating Centre for Influenza in Melbourne)
David Ferland-McCollough (Senior Scientist, RNA Technologies & Therapeutics)
Duccio Medini (R3 Program Director, Wellcome Leap & Strategic Data Science Director, Toscana Life Sciences Foundation)
More information can be found here!
